Surgical excision margins for melanoma in situ
- PMID: 24444795
- DOI: 10.1016/j.bjps.2013.11.014
Surgical excision margins for melanoma in situ
Abstract
Introduction: Melanoma in situ (MIS) is a non-invasive lesion accounting for up to 27% of all melanomas by Coory et al. (2006).(1) MIS may be a precursor to invasive disease. The Lentigo Maligna (LM) subgroup of MIS carries upto a 4.7% lifetime risk of developing an invasive component by Agarwal-Antal et al. (2002).(2) Surgical excision is recommended however other modalities of treatments are possible. In this study we aim to assess whether histological margins following excision of in situ melanoma has any bearing on recurrence or progression to malignancy.
Method: We retrospectively reviewed data accumulated on all melanomas referred to the hospital between the dates of February 2001 to February 2009. We identified all patients with melanoma in situ and for these patients recorded age, sex, anatomical site of lesion, histological type, histological excision margin, recurrence after excision and transformation to malignant melanoma.
Results: A total of 2121 patents were identified having been diagnosed and treated for melanoma of which 192 cases were identified with melanoma in situ representing 9.1% of all melanomas treated. 38% of all the lesions were of the LM subgroup. We noted a higher incomplete excision rate in this subgroup (p < 0.01) compared to the non-LM subgroup. We only noted two recurrences following complete excision (1.1%) and one recurrence in lesions completely excised with histological margins less than 2 mm (1.4%). Both of the lesions that recurred following complete excision were LM lesions. Recurrence following complete excision of LM was 2.9%.
Conclusion: Our data suggests that MIS lesions that were not LM and adequately excised even with narrow margins are unlikely to recur therefore reducing the need for wider excision. LM however poses a more challenging clinical problem not only with the higher inadequate primary excision and higher recurrence rates following excision but also the fact that it occurs in much older patients who may be less able to tolerate more extensive surgery. In keeping with the literature we would suggest treating LM lesions more aggressively if possible.
Keywords: Excision margins; Melanoma in situ.
Copyright © 2013 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
Comment in
-
Surgical excision margins for melanoma in situ: the experience at the Brescia Melanoma Centre, Italy.J Plast Reconstr Aesthet Surg. 2014 Sep;67(9):1297-8. doi: 10.1016/j.bjps.2014.04.009. Epub 2014 May 2. J Plast Reconstr Aesthet Surg. 2014. PMID: 24838276 No abstract available.
Similar articles
-
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.Int J Dermatol. 2010 May;49(5):482-91. doi: 10.1111/j.1365-4632.2010.04423.x. Int J Dermatol. 2010. PMID: 20534080 Review.
-
Staged margin control techniques for surgical excision of lentigo maligna.G Ital Dermatol Venereol. 2009 Jun;144(3):259-70. G Ital Dermatol Venereol. 2009. PMID: 19528907 Review.
-
Staged excision for lentigo maligna and lentigo maligna melanoma: A retrospective analysis of 117 cases.J Am Acad Dermatol. 2008 Jan;58(1):142-8. doi: 10.1016/j.jaad.2007.09.023. Epub 2007 Oct 29. J Am Acad Dermatol. 2008. PMID: 18029055
-
Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision.Arch Dermatol. 2004 Sep;140(9):1087-92. doi: 10.1001/archderm.140.9.1087. Arch Dermatol. 2004. PMID: 15381549
-
Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma.Ophthalmology. 2003 Oct;110(10):2011-8. doi: 10.1016/S0161-6420(03)00670-5. Ophthalmology. 2003. PMID: 14522781
Cited by
-
Malignant melanoma: evolving practice management in an era of increasingly effective systemic therapies.Curr Probl Surg. 2022 Jan;59(1):101030. doi: 10.1016/j.cpsurg.2021.101030. Epub 2021 Jul 7. Curr Probl Surg. 2022. PMID: 35033317 Free PMC article. Review. No abstract available.
-
Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.Adv Ther. 2021 Jul;38(7):3506-3530. doi: 10.1007/s12325-021-01783-x. Epub 2021 May 28. Adv Ther. 2021. PMID: 34047915 Free PMC article. Review.
-
Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision.J Skin Cancer. 2020 Oct 29;2020:8813050. doi: 10.1155/2020/8813050. eCollection 2020. J Skin Cancer. 2020. PMID: 33178463 Free PMC article.
-
Melanoma in situ (MIS) in a patient with atypical mole syndrome (AMS): with aggressiveness to success?Wien Med Wochenschr. 2017 Apr;167(5-6):114-116. doi: 10.1007/s10354-016-0503-9. Epub 2016 Sep 6. Wien Med Wochenschr. 2017. PMID: 27600562 No abstract available.
-
An assessment of histological margins and recurrence of melanoma in situ.Plast Reconstr Surg Glob Open. 2015 Mar 6;3(2):e301. doi: 10.1097/GOX.0000000000000272. eCollection 2015 Feb. Plast Reconstr Surg Glob Open. 2015. PMID: 25750840 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical